Zealand Pharma获得Royalty Pharma（RPRX:NASDAQ）1亿美元融资
· seekingalpha.com
Royalty Pharma向Zealand提供1亿美元，用于rusfertide（PTG-300）在真性红细胞增多症中的特许权使用费。更多详情请点击此处。
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...